Advertisement
Canada markets close in 2 hours 5 minutes
  • S&P/TSX

    21,634.27
    -21.78 (-0.10%)
     
  • S&P 500

    5,008.40
    -13.81 (-0.27%)
     
  • DOW

    37,705.56
    -47.75 (-0.13%)
     
  • CAD/USD

    0.7257
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    82.89
    +0.20 (+0.24%)
     
  • Bitcoin CAD

    86,399.87
    +2,404.11 (+2.86%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,399.80
    +11.40 (+0.48%)
     
  • RUSSELL 2000

    1,949.68
    +1.74 (+0.09%)
     
  • 10-Yr Bond

    4.6430
    +0.0580 (+1.26%)
     
  • NASDAQ

    15,613.26
    -70.11 (-0.45%)
     
  • VOLATILITY

    18.14
    -0.07 (-0.38%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6814
    +0.0012 (+0.18%)
     

Complimentary Technical Snapshots on DaVita and Three More Specialized Health Services Stocks

Stock Research Monitor: ACHC, MD, and TVTY

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on DVA sign up now at www.wallstequities.com/registration. WallStEquities.com draws investors' attention to four Specialized Health Services stocks, particularly, Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), MEDNAX Inc. (NYSE: MD), and Tivity Health Inc. (NASDAQ: TVTY). These companies operate in the Healthcare sector, which makes and sells drugs. Other companies perform biotechology and produce and sell medical equipment.All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Acadia Healthcare

Shares in Franklin, Tennessee headquartered Acadia Healthcare Co. Inc. saw a decline of 1.59%, ending Thursday's trading session at $40.85. The stock recorded a trading volume of 815,727 shares. The Company's shares have gained 4.26% over the last three months. The stock is trading 0.79% and 7.90% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities, have a Relative Strength Index (RSI) of 49.13. Get the full research report on ACHC for free by clicking below at:

ADVERTISEMENT

www.wallstequities.com/registration/?symbol=ACHC


DaVita

Denver, Colorado headquartered DaVita Inc.'s stock declined slightly by 0.92%, closing the day at $70.15 with a total trading volume of 1.09 million shares. The Company's shares have advanced 2.62% in the past month, 6.38% in the previous three months, and 8.39% over the past year. The stock is trading 3.88% and 5.29% above its 50-day and 200-day moving averages, respectively. Additionally, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 51.99.

On June 06th, 2018, DaVita Kidney Care, a division of DaVita, and theUniversity of Chicago Medicine announced the successful implementation of the Transplant Waitlist Support Program, which was created to help keep waitlisted patients transplant-ready by proactively and electronically exchanging patient information between the Company and the transplant center. Access the free research report on DVA now by signing up at:


www.wallstequities.com/registration/?symbol=DVA


MEDNAX

On Thursday, shares in Sunrise, Florida-based MEDNAX Inc. recorded a trading volume of 612,803 shares. The stock ended the day 0.88% higher at $43.37. The Company's shares are trading below their 50-day moving average by 7.03%. Furthermore, shares of MEDNAX, which together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 36.28.

On June 01st, 2018, MedData, Inc., a MEDNAX (MD) company, announced Emily Fisher as Acting President. Ms. Fisher will report directly to Joe Calabro, President of MD. She is taking over for Ann Barnes, who announced in May that she would be stepping down as president and CEO on June 15th, 2018, to pursue other opportunities. Are you already registered with Wall St. Equities? Do so now for free, and get the report on MD at:

www.wallstequities.com/registration/?symbol=MD


Tivity Health

Franklin, Tennessee headquartered Tivity Health Inc.'s stock rose slightly by 0.42%, finishing yesterday's session at $35.90 with a total trading volume of 445,647 shares. The Company's shares have advanced 0.56% in the last month. The stock is trading below its 50-day moving average by 1.17%. Additionally, shares of Tivity Health, which provides fitness and health improvement programs in the US, have an RSI of 57.26.

On June 04th, 2018, research firm Chardan Capital Markets upgraded the Company's stock rating from ‘Neutral' to ‘Buy', with a target price of $42 per share.

On June 14th, 2018, Tivity Health announced that the Company has added two new members to its Board of Directors. Sara J. Finley, Principalof Threshold Corporate Consulting, LLC, a consulting services firm that she founded in 2015; and Beth M. Jacob, Senior Vice President, Strategic Advisor and Leadership Coach for SPS Commerce, were elected on May 24th, 2018, at the Company's annual meeting. Aspiring Member, please take a moment to register below for your free research report on TVTY at:

www.wallstequities.com/registration/?symbol=TVTY

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities